A family case report of Neurofibromatosis
DOI:
https://doi.org/10.12775/JEHS.2022.12.02.012Keywords
neurofibromatosis, NF1, NF2, von Recklinghausen’s diseaseAbstract
Neurofibromatosis is a genetic disease inherited in an autosomal, dominant manner. The course of von Recklinghausen’s disease varies from patient to patient. Most cases are mild and uncomplicated. The diagnosis of NF1 is based on the criteria of the National Institutes of Health (NIH). Type 2 neurofibromatosis is inherited, in most cases autosomal dominantly. The abnormal allele can be inherited from either parent, with the risk of passing the gene on to the offspring from the parent, being 50%. This article describes the familial form of neurofibromatosis. In the case in question, all three sisters were found to be mutated in the NF1 gene by genetic testing. In the same family, the clinical manifestation of the disease may be different for sisters and children. Due to compliance with medical recommendations, the disease does not significantly affect the quality of life of the families affected.
References
Le C, Bedocs PM. Neurofibromatosis. 2021 Oct 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 29083784.
Ghalayani P, Saberi Z, Sardari F. Neurofibromatosis type I (von Recklinghausen's disease): A family case report and literature review. Dent Res J (Isfahan). 2012 Jul;9(4):483-8. [PMC free article] [PubMed] [Reference list]
Adil A, Koritala T, Singh AK. Neurofibromatosis Type 1. 2021 Sep 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 29083628.
Seminog OO, Goldacre MJ. Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer. 2013 Jan 15;108(1):193-8. [PMC free article] [PubMed] [Reference list]
Gürsoy S, Erçal D. Genetic Evaluation of Common Neurocutaneous Syndromes. Pediatr Neurol. 2018 Dec;89:3-10. [PubMed] [Reference list]
Lorenzo J, Barton B, Arnold SS, North KN. Developmental trajectories of young children with neurofibromatosis type 1: a longitudinal study from 21 to 40 months of age. J Pediatr. 2015 Apr;166(4):1006-12.e1. [PubMed] [Reference list]
National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987.
DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000 Mar;105(3 Pt 1):608-14. [PubMed] [Reference list]
Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15(6):541-55. [PubMed] [Reference list]
Kim YM. Improving the lives of children with neurofibromatosis type 1. Clin Exp Pediatr. 2021 Apr;64(4):165-166. doi: 10.3345/cep.2020.01277. Epub 2020 Sep 18. PMID: 32972053; PMCID: PMC8024116.
Kang E, Yoon HM, Lee BH. Neurofibromatosis type I: points to be considered by general pediatricians. Clin Exp Pediatr. 2021 Apr;64(4):149-156. doi: 10.3345/cep.2020.00871. Epub 2020 Jul 15. PMID: 32683805; PMCID: PMC8024119.
Tiwari R, Singh AK. Neurofibromatosis Type 2. 2021 Oct 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 29261934.
Wippold FJ, Lubner M, Perrin RJ, Lämmle M, Perry A. Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns. AJNR Am J Neuroradiol. 2007 Oct;28(9):1633-8. [PMC free article] [PubMed] [Reference list]
Smith MJ, Bowers NL, Bulman M, Gokhale C, Wallace AJ, King AT, Lloyd SK, Rutherford SA, Hammerbeck-Ward CL, Freeman SR, Evans DG. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis. Neurology. 2017 Jan 03;88(1):87-92. [PMC free article] [PubMed] [Reference list]
Mautner VF, Nguyen R, Kutta H, Fuensterer C, Bokemeyer C, Hagel C, Friedrich RE, Panse J. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol. 2010 Jan;12(1):14-8. [PMC free article] [PubMed] [Reference list]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Daniel Wolder, Adrian Swat
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 529
Number of citations: 0